100 related articles for article (PubMed ID: 10844128)
1. Characterisation of the effects of SR146131, a novel non-peptide CCK(1) receptor agonist, on IMR-32 human neuroblastoma cells.
Schaeffer P; Nestor AL; Prabonnaud V; Bachy A; Laplace MC; Keane PE; Bignon E; Herbert JM
Eur J Pharmacol; 2000 Jun; 397(2-3):303-10. PubMed ID: 10844128
[TBL] [Abstract][Full Text] [Related]
2. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
Bignon E; Bachy A; Boigegrain R; Brodin R; Cottineau M; Gully D; Herbert JM; Keane P; Labie C; Molimard JC; Olliero D; Oury-Donat F; Petereau C; Prabonnaud V; Rockstroh MP; Schaeffer P; Servant O; Thurneyssen O; Soubrié P; Pascal M; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648
[TBL] [Abstract][Full Text] [Related]
3. CCK-JMV-180 acts as an antagonist of the CCKA receptor in the human IMR-32 neuroblastoma cell line.
Schaeffer P; Prabonnaud V; Roux M; Gully D; Herbert JM
FEBS Lett; 1994 Nov; 354(2):203-6. PubMed ID: 7957924
[TBL] [Abstract][Full Text] [Related]
4. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI.
Shilling PD; Feifel D
Psychopharmacology (Berl); 2002 Nov; 164(3):285-93. PubMed ID: 12424552
[TBL] [Abstract][Full Text] [Related]
5. Influences of cholecystokinin octapeptide on phosphoinositide turnover in neonatal-rat brain cells.
Zhang LJ; Lu XY; Han JS
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):847-50. PubMed ID: 1323276
[TBL] [Abstract][Full Text] [Related]
6. Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin.
Smith AJ; McKernan RM
Br J Pharmacol; 1999 Jan; 126(1):79-86. PubMed ID: 10051123
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line.
Lignon MF; Bernad N; Martinez J
Eur J Pharmacol; 1993 May; 245(3):241-6. PubMed ID: 8335062
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.
Harper EA; Griffin EP; Shankley NP; Black JW
Br J Pharmacol; 1999 Mar; 126(6):1496-503. PubMed ID: 10217545
[TBL] [Abstract][Full Text] [Related]
9. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
[TBL] [Abstract][Full Text] [Related]
10. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.
Staley J; Jensen RT; Moody TW
Peptides; 1990; 11(5):1033-6. PubMed ID: 2178246
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of CCKB receptors on GH3 pituitary cells: receptor activation is linked to Ca2+ mobilisation.
Smith AJ; Patel S; Freedman SB
Eur J Pharmacol; 1994 Apr; 267(2):215-23. PubMed ID: 8050481
[TBL] [Abstract][Full Text] [Related]
12. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization.
Bignon E; Alonso R; Arnone M; Boigegrain R; Brodin R; Gueudet C; Héaulme M; Keane P; Landi M; Molimard JC; Olliero D; Poncelet M; Seban E; Simiand J; Soubrié P; Pascal M; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1999 May; 289(2):752-61. PubMed ID: 10215649
[TBL] [Abstract][Full Text] [Related]
13. Characterization of type A and type B CCK receptor binding sites in rat vagus nerve.
Corp ES; McQuade J; Moran TH; Smith GP
Brain Res; 1993 Sep; 623(1):161-6. PubMed ID: 8221086
[TBL] [Abstract][Full Text] [Related]
14. Essential role of extracellular charged residues of the human CCK(1) receptor for interactions with SR 146131, SR 27897 and CCK-8S.
Gouldson P; Legoux P; Carillon C; Dumont X; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 2000 Feb; 389(2-3):115-24. PubMed ID: 10688974
[TBL] [Abstract][Full Text] [Related]
15. Both CCK-A and CCK-B/gastrin receptors mediate pepsinogen release in guinea pig gastric glands.
Lin CW; Bianchi BR; Miller TR; Witte DG; Wolfram CA
Am J Physiol; 1992 Jun; 262(6 Pt 1):G1113-20. PubMed ID: 1616041
[TBL] [Abstract][Full Text] [Related]
16. Full and partial agonist activity of C-terminal cholecystokinin peptides at the cloned human CCK-A receptor expressed in Chinese hamster ovary cells.
Dunlop J; Zhang Y; Evans N
Peptides; 1997; 18(6):865-8. PubMed ID: 9285936
[TBL] [Abstract][Full Text] [Related]
17. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
Letari O; Mennuni L; Revel L; Colombo S; Makovec F
Eur J Pharmacol; 1996 Jun; 306(1-3):325-33. PubMed ID: 8813647
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain.
Boden PR; Woodruff GN; Pinnock RD
Br J Pharmacol; 1991 Mar; 102(3):635-8. PubMed ID: 1364831
[TBL] [Abstract][Full Text] [Related]
20. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
